Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Preguntas más frecuentes / Opciones para el Tratamiento / Radiooncología
Marylou S. Anton, BSN, RN, OCN
Ultima Vez Modificado: 1 de noviembre del 2001
Dear OncoLink "Ask the Experts,"
I am a radiation therapist in Canada. My department has recently been tackling the issues of cervical stenosis caused by radiation therapy (external and internal) and the use of dilators to help this problem. Would you have any information on this?
Thank you for you time.
P. W.
Marylou S. Anton, BSN, RN, OCN, Director of Nursing and Clinical Research, Department of Radiation Oncology, University of Pennsylvania responds:
A common late effect of female pelvic irradiation is fibrosis and stenosis of the vaginal canal. The possibility of this occurring increases with the use if intracavitary implants, also known as brachytherapy. This is due to the radiation denuding the vaginal epithelium by direct effect on the basal layer of the mucosa, the endothelium of the small vessels, and on the fibroblasts of the connective tissue in the submucosa. Indirectly, the vaginal mucosa is further devitalized by the narrowing and the obliteration of the small vessels and circumferential fibrosis of the perivaginal tissues.
The interventions for this late effect very important. First, if the patient has been sexually active; encouraging the patient to remain sexually active throughout treatment would be helpful. Also, the use of the vaginal dilator is very important for follow-up. Giving the patient an explanation of how and why it should be used, along with a printed instruction sheet is very important. Being with patient the first time they insert the dilator is especially helpful to make sure the correct size dilator is given as well as observing patient technique. It is important to stress the importance of the use of the dilator for keeping the vagina open for future examinations as well as sexual reasons. Some patients may shy away from using the dilator, for personal reasons. This is why we stress written instruction in our department. The following is an example of the instructions given to our patients in the Department of Radiation Oncology at the Abramson Cancer Center of the University of Pennsylvania.
A vaginal dilator is a smooth plastic cylinder measuring six inches in length. Vaginal dilators come in 3 different sizessmall, medium and large.
A possible side effect of radiation treatment is scar tissue formation, which can lead to the closing of your vagina. Over time radiation causes a decreased supply of blood to the radiated areas. This decreased blood supply shrinks or slows the growth of the cancer, but can also lead to drier, tender, less elastic tissues in the vagina. This side effect can be lessened in two ways: by regular sexual intercourse or by using a dilator with a prescribed cream or jelly. The use of a vaginal dilator or intercourse will keep the vagina open (dilated) and the tissue more elastic. This is important as it provides more comfort during pelvic exams and allows your doctor to see the treated area better.
When using the dilator:
Begin using the dilator after your radiation therapy has been completed and any vaginal irritation has decreased. This should be about 1 - 2 weeks after you finish treatment.
For the first month after you finish your radiation treatments, the dilator should be used everyday as directed above. Thereafter, the dilator should be used at least three times a week for life.
If you are sexually active you may have sexual intercourse when it becomes comfortable. Intercourse will also dilate the vagina. Therefore, if you have intercourse twice in one week, you only need to use your dilator once.
Depending on the type of cancer you have, your doctor will recommend either an estrogen cream or a water-based lubricant to be used with the dilator. Estrogen may make tissues more lubricated, elastic, and less tender. It is better to use the estrogen cream at bedtime because it stays in the vagina longer and has more time to work. If your doctor does not want you to use estrogen, a water-based lubricant such as K-Y jelly (available without a prescription at drug stores) may be used to make insertion of the dilator easier. A water-based lubricant may also be helpful for intercourse since the vagina may be dry after radiation therapy.
Dr. Wein discusses prostate cancer, screening and treatment options. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

